Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of DA-5207 Transdermal Delivery System in Healthy Adults
NCT04013477Phase 1Completed
- Sponsor
- Dong-A ST
- Start
- Jun 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of donepezil transdermal patch in Alzheimer's disease (AD) (4 arms), sponsored by Dong-A ST. Primary endpoints: Area Under the Curve at 11 days and Maximum Plasma Concentration at 11 days. Started Jun 2019; status: completed.
02
Drugs
donepezil transdermal patch
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04013477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04013477.